Fresenius Kabi Logo (Sod0y 0001 01)
Sodium Chloride Injection, Solution, Concentrate
Product Images NDC 63323-095
4 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 63323-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Sod0y 0001 02)
Package Label (PRINCIPAL DISPLAY – 23.4% Sodium Chloride Injection, USP Vial Label)
Sodium Chloride 23.4% injection concentrate label for intravenous use by Fresenius Kabi USA. The 100 mL pharmacy bulk package contains 400 mEq/100 mL (4 mEq/mL) solution. The label includes dilution caution, storage instructions, and pharmacy bulk use warning with NDC 63323-095-02.*
Package Label (PRINCIPAL DISPLAY – 23.4% Sodium Chloride Injection, USP Tray Label)
Label for Maxivial 23.4% Sodium Chloride Injection USP concentrate, 400 mg/100 mL (4 mEq/mL) in a pharmacy bulk package of 20 x 100 mL vials. The label highlights that it is preservative free, must be diluted for intravenous use, and is not for direct infusion. Manufactured by Fresenius Kabi USA, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
